Bharat Biotech seeks emergency use authorisation for indigenously developed COVID-19 vaccine Covaxin


PTI, Dec 8, 2020, 8:05 AM IST

New Delhi: After Pfizer and Serum Institute, Hyderabad-based pharmaceutical firm Bharat Biotech on Monday applied to the central drug regulator seeking emergency use authorisation for its COVID-19 vaccine Covaxin, official sources said.

Covaxin is being indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

The Hyderabad-based firm is conducting the phase-3 clinical trials of its vaccine in around 25 places, including Delhi, Mumbai, Patna and Lucknow.

The firm, while applying for the phase-3 trial, had stated that the vaccine was well-tolerated in all dose groups and no serious adverse events have been reported. The most common adverse event was transient pain at the injection site, a source said.

The Drugs Controller General of India (DCGI) had on October 23 granted permission to the firm for conducting the phase-3 clinical trial of Covaxin after assessing the safety and immunogenicity data of phase 1 and 2 trials.

An expert committee of the Central Drugs Standard Control Organisation (CDSCO) will meet on Wednesday to review applications of Pfizer, Serum Institute of India and Bharat Biotech seeking emergency use authorisation for their COVID-19 vaccine candidates.

At an all-party meeting on December 4, Prime Minister Narendra Modi had expressed hope that a COVID-19 vaccine may be ready in a few weeks. That evening, the Indian arm of US pharmaceutical giant Pfizer had sought approval for its vaccine from the central drug regulator, after the firm secured such clearance in the UK and Bahrain.

The Serum Institute sought the nod for the Oxford COVID-19 vaccine, Covishield, on December 6.

“DCGI has already started processing the applications. The subject expert committee on COVID-19 at CDSCO will deliberate on the applications by Pfizer, Serum Institute of India and Bharat Biotech seeking emergency use authorisation for their COVID-19 vaccines on December 9,” a source said.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

IMD predicts light rains at Red Fort on I-Day morning

‎Flag to be hoisted at Idgah Maidan for the first time: Araga Jnanendra‎

We’ll provide more facilities to North K’taka people in B’luru soon: CM Bommai

Over one crore cases settled in National Lok Adalat in a day: NALSA

UP’s ‘village of soldiers’ gears up to celebrate Independence Day

Many scientific concepts branded as western contributions had origin in India: RGCB chief

Bantwal DySP Pratap Thorat awarded Preisdent’s Police Medal 2022 for outstanding service


Related Articles More

IMD predicts light rains at Red Fort on I-Day morning

Over one crore cases settled in National Lok Adalat in a day: NALSA

UP’s ‘village of soldiers’ gears up to celebrate Independence Day

Many scientific concepts branded as western contributions had origin in India: RGCB chief

Independence Day an occasion to remember freedom fighters, builders of modern India: VP Dhankhar

MUST WATCH

NEWS BULLETIN 14-08-2022

Relief sculpture at Ammai School Compaound

| KABBINALE | Mysterious Waterfall Of Hebri

Shri Araga Gyanendra addressed the gathering. |udayavaninews

News bulletin 13-8-2022


Latest Additions

IMD predicts light rains at Red Fort on I-Day morning

‎Flag to be hoisted at Idgah Maidan for the first time: Araga Jnanendra‎

Royal London Cup One Day: Cheteshwar Pujara smashes career-best 174 for Sussex vs Surrey

We’ll provide more facilities to North K’taka people in B’luru soon: CM Bommai

Over one crore cases settled in National Lok Adalat in a day: NALSA

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.